Term ended Jan 15, 2024 · Medium confidence
20-year base term ended Jan 15, 2024
Why Medium: The disclaimer's references carry disclaimers of their own not yet read (US 8,618,130, US 8,921,393), so the cap could be lower.
Jan 15, 2004
Jan 15, 2024
Dec 15, 2015
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jan 15, 2004, when application 10/759,561, the earliest non-provisional in its chain, was filed (this one was filed Nov 10, 2014) | Jan 15, 2024 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 7,732,462, US 8,227,487, US 8,377,959, US 8,618,130, US 8,921,393) | resolves to Jan 15, 2024, no earlier than this term, so no change | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 2 maintenance fees paid | term ended | High confidence |
| Computed term end | The steps above, in order | Jan 15, 2024 | Medium confidence |
This family
| US 7,601,740 | In force Jan 2031 | Jan 2031 |
| US 7,732,462 | In force Dec 2026 | Dec 2026 |
| US 7,994,193 | Term ended Jan 2024 | Jan 2024 |
| US 8,227,487 | Term ended Jan 2024 | Jan 2024 |
| US 8,377,959 | Term ended Jan 2024 | Jan 2024 |
| US 8,618,130 | Term ended no later than Jan 2024 | no later than Jan 2024 |
| US 8,921,393 | Term ended no later than Jan 2024 | no later than Jan 2024 |
| US 9,211,289 | this patent Jan 2024 | Jan 2024 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Nov 30, 2021 Reel 58945, frame 485 | Acadia Pharmaceuticals Inc. | Acadia Pharmaceuticals Inc. | Assignee Change of Address |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
A terminal disclaimer resolved from the filed document, referencing US 7,732,462, US 8,227,487, US 8,377,959, US 8,618,130, US 8,921,393, ends no earlier than this term, so it caps nothing.